Drugmaker Sues Credit Suisse Over Risky Investments

Swiss drugmaker Roche Holding has sued Credit Suisse over risky investments sold by two former directors charged with fraud.

  • 20 Oct 2009
Swiss drugmaker Roche Holding has sued Credit Suisse over risky investments sold by two former directors charged with fraud. Filed in U.S. District Court for the Southern District of New York, the lawsuit alleges that the bank fraudulently invested more than $545 million of Roche's cash in “collateralized ...

Please take a trial or subscribe to access this content.

Contact Mark Goodes to discuss your access: mark.goodes@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Share % by Volume
1 Societe Generale 15.35
2 Rabobank 14.41
3 Morgan Stanley 11.73
4 Barclays 8.99
5 Credit Agricole 7.57

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 27 Feb 2017
1 Wells Fargo Securities 11,897.40 33 11.83%
2 Bank of America Merrill Lynch 9,837.56 29 9.78%
3 Citi 9,714.54 32 9.66%
4 JPMorgan 7,997.38 24 7.95%
5 Credit Suisse 6,335.67 14 6.30%